This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03723967
Recruitment Status : Recruiting
First Posted : October 30, 2018
Last Update Posted : October 4, 2022
Information provided by (Responsible Party):
Centre Leon Berard

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : August 2024